Roflumilast

FDA Approved: * March 30, 2020
Pharm Company: * STRIDES PHARMA
Category: Lungs (Pulmonary)

Roflumilast, sold under the trade name Daxas among others, is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).[6][7][8][9] In June 2010, it was approved in the European Union for severe COPD assoc... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Roflumilast 500 ug/1 Oral Tablet
NDC: 0378-1905
Labeler:
Mylan Pharmaceuticals Inc.
Roflumilast 500 ug/1 Oral Tablet
NDC: 13668-476
Labeler:
Torrent Pharmaceuticals Limited
Roflumilast 500 ug/1 Oral Tablet
NDC: 31722-623
Labeler:
Camber Pharmaceuticals, Inc.
Roflumilast 500 ug/1 Oral Tablet
NDC: 42571-259
Labeler:
Micro Labs Limited
Roflumilast 500 ug/1 Oral Tablet
NDC: 43547-005
Labeler:
Solco Healthcare Us, LLC.
Roflumilast 500 ug/1 Oral Tablet
NDC: 64380-786
Labeler:
Strides Pharma Science Limited
Roflumilast 500 ug/1 Oral Tablet
NDC: 68382-969
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Roflumilast 500 ug/1 Oral Tablet
NDC: 70771-1674
Labeler:
Cadila Healthcare Limited
Roflumilast 500 ug/1 Oral Tablet
NDC: 72205-200
Labeler:
Novadoz Pharmaceuticals LLC
Roflumilast 250 ug/1 Oral Tablet
NDC: 72205-201
Labeler:
Novadoz Pharmaceuticals LLC

Related Brands

Drugs with the same active ingredients